These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37942621)
1. Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting. Durojaiye OC; Cole J; Kritsotakis EI J Chemother; 2024 Apr; 36(2):119-126. PubMed ID: 37942621 [TBL] [Abstract][Full Text] [Related]
2. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States. Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study. Voumard R; Gardiol C; André P; Arensdorff L; Cochet C; Boillat-Blanco N; Decosterd L; Buclin T; de Vallière S J Antimicrob Chemother; 2018 Sep; 73(9):2540-2545. PubMed ID: 29982449 [TBL] [Abstract][Full Text] [Related]
4. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. Dimitrova M; Gilchrist M; Seaton RA BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of Ceftolozane/Tazobactam administered in continuous infusion through elastomeric pumps in OPAT regimen: a case series. Giuliano G; Tarantino D; Tamburrini E; Nurchis MC; Scoppettuolo G; Raffaelli F Infect Dis (Lond); 2024 Oct; 56(10):887-893. PubMed ID: 39312499 [TBL] [Abstract][Full Text] [Related]
6. Optimising patient safety when using elastomeric pumps to administer outpatient parenteral antibiotic therapy. Oliver G Br J Nurs; 2016 Oct; 25(19):S22-S27. PubMed ID: 27792443 [TBL] [Abstract][Full Text] [Related]
7. Clinical Effectiveness of Continuous Infusion Flucloxacillin in the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting in a UK Hospital: A Service Evaluation. Clarkson AM; Snape S Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391538 [TBL] [Abstract][Full Text] [Related]
8. Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards. Jenkins A; Shanu S; Jamieson C; Santillo M Eur J Hosp Pharm; 2022 Nov; 29(6):304-307. PubMed ID: 33990388 [TBL] [Abstract][Full Text] [Related]
9. Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015-19). Gilchrist M; Barr D; Drummond F; Muir A; Williams J; Scriven J; Snape S; Hemsley C; Durojaiye CO; Patel S; Andrew Seaton R J Antimicrob Chemother; 2022 Apr; 77(5):1481-1490. PubMed ID: 35187565 [TBL] [Abstract][Full Text] [Related]
10. Outpatient parenteral antibiotic therapy (OPAT) through elastomeric continuous infusion pumps in a real-life observational study: Characteristics, safety, and efficacy analysis. Giuliano G; Tarantino D; Tamburrini E; Nurchis MC; Scoppettuolo G; Raffaelli F Enferm Infecc Microbiol Clin (Engl Ed); 2024 Dec; 42(10):581-587. PubMed ID: 38902156 [TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa. Durojaiye OC; Slucka A; Kritsotakis EI Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service. Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610 [TBL] [Abstract][Full Text] [Related]
13. Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. Schmidt-Hellerau K; Baade N; Günther M; Scholten N; Lindemann CH; Leisse C; Oberröhrmann C; Peter S; Jung N; Suarez I; Horn C; Ihle P; Küpper-Nybelen J; Hagemeier A; Hellmich M; Lehmann C Infection; 2024 Aug; 52(4):1407-1414. PubMed ID: 38478255 [TBL] [Abstract][Full Text] [Related]
14. Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy. Akahane M; Enoki Y; Saiki R; Hayashi Y; Hiraoka K; Honma K; Itagaki M; Gotoda M; Shinoda K; Hanyu S; Hamamura Y; Miyajima T; Ito C; Taguchi K; Uno S; Uwamino Y; Iketani O; Hasegawa N; Matsumoto K Int J Infect Dis; 2021 Feb; 103():464-468. PubMed ID: 33246042 [TBL] [Abstract][Full Text] [Related]
15. Implementing the First Outpatient Parenteral Antimicrobial Therapy (OPAT) Program to Utilize Disposable Elastomeric Pumps in the Gulf Region: Results From a Tertiary Teaching Hospital in the Kingdom of Saudi Arabia. Zikri A; Al-Faraj H; Kamas N; AlZahrani J; BuKhamseen H; Alshahoub W; Beltran A; Fatih D; AlMusa Z Cureus; 2021 Dec; 13(12):e20179. PubMed ID: 34900504 [TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of flucloxacillin delivery using an elastomeric device for outpatient parenteral antimicrobial therapy. Zhang Y; Ody YC; Davis L Br J Community Nurs; 2020 Aug; 25(8):376-380. PubMed ID: 32772722 [TBL] [Abstract][Full Text] [Related]
17. Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway. Bodycot J; Mashonganyika L; Kucziw N; Ingham C; Bhukera S; White HA Br J Nurs; 2021 Jan; 30(2):S4-S10. PubMed ID: 33529119 [TBL] [Abstract][Full Text] [Related]
18. [Outpatient Parenteral Antimicrobial Therapy (OPAT) with Elastomeric Pumps in Collaboration with Home-visit Nursing Services in Japan: Experience of the First 10 Patients]. Hase R; Uno S; Miyoshi K; Fujita K; Suzuki H; Suzuki D; Mikawa T; Muranaka K; Hosokawa N Kansenshogaku Zasshi; 2015 Sep; 89(5):567-73. PubMed ID: 26630787 [TBL] [Abstract][Full Text] [Related]